Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat...
54 KB (4,223 words) - 21:58, 7 September 2024
PANORAMIC trial (section Molnupiravir)
preexisting health condition. The antivirals tested in the study will be molnupiravir and nirmatrelvir/ritonavir (Paxlovid). In December 2022, results from...
6 KB (525 words) - 08:27, 20 October 2023
the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along...
7 KB (527 words) - 13:20, 15 October 2024
revealed that private firm MERCK was the sole importer of anti-COVID drugs Molnupiravir and Ronapreve on the island of Mauritius. Kailesh Jagutpal further revealed...
20 KB (2,152 words) - 08:07, 13 October 2024
include molnupiravir, high-dose nitazoxanide, the monoclonal antibody Vir 7832, intravenous favipiravir, and the combination of molnupiravir plus nirmatrelvir/ritonavir...
8 KB (878 words) - 05:24, 13 July 2024
Feline infectious peritonitis (section Molnupiravir)
of Cyprus, on 8 August 2023 the government released 80,000 anti-COVID molnupiravir pills from its national COVID-19 stockpile, in a bid to solve the feline...
26 KB (2,878 words) - 20:13, 28 August 2024
COVID-19 drug development (section Molnupiravir)
molnupiravir's mutagenic effects could create new variants that evade immunity and prolong the COVID‑19 pandemic. In September 2023, molnupiravir's vial...
90 KB (13,195 words) - 04:28, 26 July 2024
adjusted its treatment guidelines. Among other changes, remdesivir and molnupiravir were now recommended only for the most severe cases, and deuremidevir...
369 KB (32,740 words) - 18:58, 9 November 2024
being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
288 KB (33,185 words) - 16:47, 7 November 2024
being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
67 KB (6,361 words) - 23:43, 27 October 2024
Minaprine Mirtazapine Misoprostol - Hospital authorization only. Moclobemide Molnupiravir Moperone Naloxone Naltrexone Nefazodone Nialamide Isobutyl nitrite Isopentyl...
26 KB (1,722 words) - 09:50, 2 November 2024
health and nutrition products including the oral anti covid medication Molnupiravir & Nirmatrelvir co-packaged with Ritonavir and injectable Remdesivir....
4 KB (256 words) - 13:52, 6 June 2024
HIV Loviride HIV Maraviroc HIV entry inhibitor Methisazone Smallpox Molnupiravir COVID-19 viral RNA polymerase inhibitor Moroxydine Influenza Nelfinavir...
13 KB (513 words) - 14:31, 4 May 2024
COVID-19 antivirals including paxlovid (nirmatrelvir/ritonavir) and molnupiravir on acute COVID-19 outcomes and long COVID. Including work which evaluated...
14 KB (1,452 words) - 17:40, 6 November 2024
in funding to help develop Molnupiravir. Merck & Co. partnered with Ridgeback to perform clinical trials with Molnupiravir in humans to treat COVID-19...
6 KB (547 words) - 14:35, 30 October 2023
treat millions of people in countries such as Yemen and African nations. Molnupiravir is an antiviral pill to treat COVID-19, developed in partnership with...
99 KB (9,725 words) - 22:20, 5 November 2024
of other antiviral drugs targeting COVID-19, including remdesivir and molnupiravir. In a study of 428 patients, viral load was reduced, but symptoms were...
17 KB (1,315 words) - 05:08, 2 November 2024
(SARS-CoV-2) Coronaviridae droplet contact coronavirus disease 2019 (COVID-19) Molnupiravir, Nirmatrelvir/ritonavir hand washing covering mouth when coughing or...
36 KB (1,249 words) - 10:35, 10 July 2024
Merck Sharp & Dohme (MSD) to purchase the experimental antiviral pill molnupiravir. If approved by Medsafe, Pharmac will be supplied with 60,000 courses...
266 KB (17,636 words) - 23:35, 4 September 2024
Government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. The Malaysian Deputy Education Minister...
25 KB (1,876 words) - 05:06, 24 June 2024
government unit in the country to procure anti-COVID-19 medicines such as Molnupiravir, Remdesivir, Tocilizumab, Baricitinib, and Bexovid for aged 12 and above...
184 KB (16,206 words) - 14:16, 8 November 2024
speed of classical supercomputers. Scientists report that repurposed Molnupiravir can completely suppress SARS-CoV-2 transmission within 24 hours in ferrets...
152 KB (27,256 words) - 16:36, 5 October 2024
(~380 patients × 2) clinical trial launched a year ago reports that molnupiravir substantially reduced the risk of hospitalization (7.3% to 14.1%) and...
299 KB (39,012 words) - 16:36, 5 October 2024
Sotrovimab Tixagevimab/cilgavimab Tocilizumab Small molecule antivirals Broad-spectrum Ensitrelvir Molnupiravir Remdesivir Co-packaged Nirmatrelvir ritonavir...
180 KB (23,898 words) - 14:59, 19 August 2024
for vulnerable patients to obtain a range of drugs including paxlovid, molnupiravir, and remdesivir. Timeline of the COVID-19 pandemic in July 2022 Responses...
3 KB (200 words) - 23:00, 28 August 2024
of the replication inhibition of the corona virus by Remdesivir and Molnupiravir 2004 Roche Symposium Award (Leading chemists of the next decade), Basel...
9 KB (984 words) - 15:37, 18 October 2024
support in hospitals. The PANORAMIC study, which examined the efficacy of molnupiravir and Paxlovid, was awarded the Prix Galien for its design and implementation...
48 KB (4,425 words) - 14:21, 24 October 2024
different standard than the other big pharma trials, with Paxlovid and molnupiravir and the monoclonals. Acetylcysteine is being considered as a possible...
128 KB (14,818 words) - 14:23, 18 October 2024
government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. Under the Movement Control Order put in...
221 KB (16,305 words) - 16:25, 19 August 2024
the country to purchase and procure anti-COVID-19 medicines such as Molnupiravir, Remdesivir, Tocilizumab, Baricitinib, and Bexovid for aged 12 and above...
180 KB (17,271 words) - 03:04, 28 May 2024